NORSA PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Copy
CopyKey data
Status
KRS number
CopyREGON
CopyNIP/VAT code
CopyVAT registration date
VAT status
Bankruptcy proceedings
NORSA PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Contacts
Registered address
Copy
Website
WWW.NORSAPHARMA.EU
B
HighReliability
B - HighIncorporation date
26/01/2015Share capital
7,500.00 PLNPrimary activity
Production of meat substitutes (10.89.A - PKD 2025)Representatives
1Representatives rights
W PRZYPADKU ZARZĄDU JEDNOOSOBOWEGO DO SKŁADANIA OŚWIADCZEŃ WOLI W IMIENIU SPÓŁKI UPRAWNIONY JEST JEDYNY CZŁONEK ZARZĄDU. W PRZYPADKU ZARZĄDU WIELOOSOBOWEGO DO SKŁADNIA OŚWIADCZEŃ WOLI W IMIENIU SPÓŁKI WYMAGANE JEST WSPÓŁDZIAŁANIE DWÓCH CZŁONKÓW ZARZĄDU LUB JEDNEGO CZŁONKA ZARZĄDU Z PROKURENTEM.Representatives
Business linkages
Premium users: 1.00 credit
Financial report (Okredo)
Premium users: 1.00 credit
People
Representatives
Person  | Title |
|---|---|
M****** Ł***** D*** | Chairman of the management board |
Persons with Significant Control
Persons with Significant Control
This information is available in our reports and to subscription users.Financial ratios
Net Profit (zł)
7,490,036Net Profit (zł)
7,490,036Financial report (Okredo)
Premium users: 1.00 credit
| Indicator |
|---|
| Turnover (zł) |
| Profit before tax (zł) |
| Net Profit (zł) |
Working capital requirement (%) The working capital requirement indicator shows how much funds a company needs to develop and maintain a business. |
| Liquidity ratioliquidityRatio |
| Net profitability (%)This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales. |
| Equity (zł) |
| Current liabilities (zł) |
| Non current liabilities (zł) |
| Non-current Assets (zł) |
| 2022 |
|---|
| 4,378,441 |
| - |
| 834,440 |
| 0.69 |
| - |
| 19.06 |
| 2,963,367 |
| 0 |
| 65,394 |
| 1,177,818 |
| 2023 |
|---|
| 7,385,983 |
| 2,485,759 |
| 2,262,271 |
| 0.64 |
| 11.89 |
| 30.63 |
| 4,976,639 |
| 435,824 |
| 0 |
| 709,491 |
| 2024 |
|---|
| 19,257,348 |
| 9,218,700 |
| 7,490,036 |
| 0.58 |
| 6.27 |
| 38.89 |
| 11,335,674 |
| 2,104,326 |
| 0 |
| - |
| 2024 |
|---|
| 19,257,348 |
| 9,218,700 |
| 7,490,036 |
| 0.58 |
| 6.27 |
| 38.89 |
| 11,335,674 |
| 2,104,326 |
| 0 |
| - |
Turnover (zł)
2024
Turnover (zł)
19,257,348 zł
161 % *
Profit before tax (zł)
9,218,700 zł271 % *
Net Profit (zł)
7,490,036 zł231 % *
Working capital requirement (%)
0.58 
-9.38 % *
Liquidity ratio
6.27 
-47.27 % *
Net profitability (%)
38.89 %26.97 % *
Equity (zł)
11,335,674 zł128 % *
Current liabilities (zł)
2,104,326 zł383 % *
Non current liabilities (zł)
0 zł
- *
Non-current Assets (zł)
-Credit history
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
Credit report
Creditor/Data source | Debt amount | Debt date | Debt type |
|---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date | Payment date | Debt type |
|---|---|---|---|---|
- | - | - | - | - |
Documents
NORSA PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ Documents
Date | Description |
|---|---|
09/04/2025 | OD 01.01.2024 DO 31.12.2024 |
13/07/2024 | OD 01.01.2023 DO 31.12.2023 |
13/07/2023 | OD 01.01.2022 DO 31.12.2022 |
13/10/2022 | OD 01.01.2021 DO 31.12.2021 |
14/10/2021 | OD 01.01.2020 DO 31.12.2020 |